We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Tomatoes Contain a Nutrient that Prevents Vascular Diseases

By LabMedica International staff writers
Posted on 17 Jan 2011
A new study had discovered that tomatoes contain 9-oxo-octadecadienoic (9-oxo-ODA), a nutrient with antidyslipidemic affects that could help tackle the onset of vascular diseases.

Researchers from Kyoto University (Japan) conducted a study to identify beneficial compounds that could improve abnormalities of lipid metabolism, primarily as part of an effort to find extracts which tackle dyslipidemia, a condition which is caused by an abnormal amount of lipids--such as cholesterol or fat--in the blood stream. More...
They focused on the activation of peroxisome proliferator-activated receptor (PPAR ) and attempted to detect compounds that activate PPAR in tomatoes. To do so, the researchers screened fractions of tomato extracts using PPAR luciferase reporter assay, and found one fraction, rechromatographed-fraction eluted in 57 min (RF57), that significantly increased PPAR reporter activity.

They found that RF57 fraction significantly increased the mRNA expression levels of PPAR target genes involved in fatty acid oxidation and O2 consumption in mouse primary hepatocytes, and inhibited cellular triglyceride accumulation. Based on liquid chromatography-mass spectrometry (LC/MS) and nuclear magnetic resonance (NMR) analyses, the researchers then determined the chemical structure of the active compound in RF57 as 9-oxo-ODA. The study was published early online on January 7, 2011, in Molecular Nutrition & Food Research.

"Finding a compound which helps the prevention of obesity-related chronic diseases in foodstuffs is a great advantage to tackling these diseases," said lead author Teruo Kawada, PhD, of the laboratory of molecular function of food, and colleagues. "It means that the tomato allows people to easily manage the onset of dyslipidemia through their daily diet."

Tomatoes contain large amounts of vitamin C, providing 40% of the daily value (DV). They also contain 15% DV of vitamin A, 8% DV of potassium, and 7% of the recommended dietary allowance (RDA) of iron for women and 10% RDA for men. The red pigment contained in tomatoes is called lycopene, which acts as an antioxidant, neutralizing free radicals. A study by Harvard researchers found that men who consumed 10 servings of tomatoes a week could cut the risk of developing prostate cancer by 45%, while 7 servings of raw tomatoes lower the risk of developing rectal colon or stomach cancers by 60%.

Related Links:
Kyoto University


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
HPV Test
Allplex HPV28 Detection
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: Shutterstock

Blood Test Could Guide Drug Selection to Prevent Repeat Heart Attacks and Strokes

Secondary prevention after myocardial infarction or stroke relies on antiplatelet therapy, yet responses vary widely and both recurrent thrombosis and bleeding remain persistent risks. In the United Kingdom,... Read more

Molecular Diagnostics

view channel
Image: Signatera uses ctDNA analysis to identify residual tumor-derived genetic material after definitive treatment (image credit: Adobe Stock)

Blood-Based MRD Test Predicts Recurrence Risk After Lung Cancer Surgery

Assessing recurrence risk after surgery for early-stage non-small cell lung cancer remains challenging, complicating adjuvant therapy and surveillance decisions. Blood-based molecular residual disease... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Type 1 diabetes affects more than 9 million people worldwide and can begin years before symptoms appear, making early identification of at-risk children difficult (Image Credit: iStock)

Early-Life Gut Microbiome Changes May Help Assess Type 1 Diabetes Risk

Type 1 diabetes (T1D) affects more than 9 million people worldwide, including 1.8 million children and adolescents, and often begins years before symptoms appear. Early identification of children who are... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: Central to the collaboration is the Enhanced Liver Fibrosis (ELF) test, a noninvasive blood test authorized in the U.S. to assess disease progression risk in patients with advanced fibrosis due to MASH and support patient management decisions. (Photo courtesy of Siemens Healthineers)

Siemens Healthineers and Novo Collaborate to Expand Access to Noninvasive Liver Testing

Metabolic dysfunction‑associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction‑associated steatohepatitis (MASH), affect millions and are linked to obesity, type 2 diabetes,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.